early intervention

R&D

Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.

Oncology

Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.